Tissue-Driven Insights For Discovery And Trials

Precision for Medicine offers a globally harmonized suite of IHC and multiplex immunofluorescence (mIF) services designed to transform raw tissue samples into quantitative, trial-ready endpoints. By leveraging a library of over 400 IHC markers and the ability to map up to 60 biomarkers simultaneously with single-cell spatial resolution, these solutions provide the deep immune phenotyping and TME characterization necessary for confident clinical decisions.

The service model integrates board-certified pathology expertise with custom assay design and CAP/CLIA-compliant validation. This comprehensive approach, supported by regulatory guidance and advanced AI-driven analysis, ensures that researchers can accurately reveal and validate biomarkers across the entire translational spectrum.